Unable to Answer Question - Insufficient Patient Information
I cannot answer this question because it lacks the essential patient-specific information required to provide a meaningful response.
Missing Critical Information
The question asks "What was the GLP-1 used by [PATIENT] in [YEAR]" but does not specify:
- Which patient - No patient identifier, name, or case details provided
- Which year - No specific year mentioned
- Any clinical context - No medical history, indication, or treatment details
What Would Be Needed to Answer
To provide an accurate answer about which GLP-1 receptor agonist a specific patient used, I would need:
- Patient identification or case description
- Specific year of treatment
- Clinical indication (type 2 diabetes, obesity, cardiovascular disease)
- Treatment history or medical records indicating which medication was prescribed
Available GLP-1 Receptor Agonists by Approval Timeline
If you can provide the missing patient and year information, here are the GLP-1 receptor agonists that have been available:
- Exenatide (Byetta) - Approved 2005, twice-daily dosing 1, 2
- Liraglutide (Victoza) - Approved 2010, once-daily dosing 1, 3
- Exenatide extended-release (Bydureon) - Approved 2011, once-weekly dosing 1, 2
- Lixisenatide - Once-daily dosing 1, 2
- Albiglutide - Once-weekly dosing 1, 2
- Dulaglutide (Trulicity) - Once-weekly dosing 1
- Semaglutide (Ozempic/Wegovy) - Once-weekly injectable or oral daily 4, 1
- Tirzepatide (Mounjaro/Zepbound) - Dual GIP/GLP-1 agonist, once-weekly 4
Please provide the specific patient details and year so I can give you an accurate answer about which GLP-1 receptor agonist was used.